Tesamorelin 10mg / Ipamorelin 3mg

$ 129.00

All products are for laboratory research purposes only. Not for human consumption, medical, or veterinary use. Novara Peptides does not condone or support the use of peptides outside of controlled scientific research. By purchasing, you acknowledge that you are a qualified researcher or institution. You must be 21 or older.

Out of stock

f1
f2
f3
f4
Category
Tesamorelin/Ipamorelin (10 mg)

Research-Grade Growth Hormone Secretagogue Blend
Tagline: GH Axis & Metabolic Function Research Formula


Product Description

Tesamorelin/Ipamorelin is a dual peptide formulation combining two potent growth hormone–releasing compounds with complementary mechanisms of action.

  • Tesamorelin is a synthetic analog of Growth Hormone–Releasing Hormone (GHRH) that stimulates GH secretion via direct activation of GHRH receptors in the pituitary.

  • Ipamorelin is a selective growth hormone secretagogue (GHS) that activates ghrelin receptors (GHSR-1a), promoting GH release through a distinct signaling pathway.

Together, this combination provides a synergistic research model for studying growth hormone dynamics, IGF-1 regulation, fat metabolism, and muscle development.

For Laboratory and Scientific Research Use Only. Not for Human Consumption.


Why Researchers Choose Tesamorelin/Ipamorelin
  • Dual Pathway GH Stimulation: Combines GHRH and GHS receptor activation for enhanced GH release.

  • Metabolic Function Studies: Used in models of adipose metabolism, IGF-1 signaling, and energy balance.

  • Anabolic & Regenerative Research: Investigated for tissue repair, muscle growth, and cellular recovery.

  • Improved Lipid Mobilization: Tesamorelin supports visceral fat reduction and lipid oxidation pathways.

  • High Purity & Stability: ≥98% peptide purity verified via HPLC and MS analysis.


Important Note

For laboratory and scientific research only. Not for human consumption, therapeutic, or diagnostic use.

Compound NameTesamorelin/Ipamorelin (Dual Peptide Complex)
Chemical ClassGrowth Hormone Secretagogue & GHRH Analog
Chemical Formula (Tesamorelin)C221H366N72O67S
Chemical Formula (Ipamorelin)C38H49N9O5
Molecular Mass (Combined)~5135 Da
FormLyophilized peptide powder
Storage Conditions–20 °C (dry), 2–8 °C (after reconstitution)
Intended Research UseGrowth hormone, IGF-1, metabolism, and regenerative studies
Research Applications

Growth Hormone Secretion & Endocrine Regulation

The Tesamorelin/Ipamorelin combination has been shown to synergistically elevate GH secretion by stimulating both GHRH and GHS receptors, creating a potent dual activation of the somatotropic axis [Bowers 2001].

Metabolic & Lipolytic Research

Tesamorelin increases lipolysis and fatty acid oxidation, reducing visceral adipose tissue while maintaining lean mass in metabolic disorder models [Falutz 2010]. Ipamorelin complements this by enhancing GH pulsatility without affecting cortisol or prolactin levels [Raun 1998].

Muscle & Tissue Regeneration

Through GH/IGF-1 signaling activation, this dual blend promotes protein synthesis, muscle regeneration, and recovery, serving as a research model for cellular growth and differentiation studies [Veldhuis 2005].

Neuroprotective & Mitochondrial Studies

GH and IGF-1 have demonstrated neuroprotective and mitochondrial support roles, suggesting potential utility for investigating neurodegenerative and aging-related processes [Frohman 2000].


References

  1. Bowers CY. (2001). Growth Hormone Secretagogues: Basic Principles and Clinical Implications. Endocrine Reviews.
    https://academic.oup.com/edrv/article/22/6/723/2425349

  2. Falutz J, et al. (2010). Tesamorelin, a Growth Hormone–Releasing Factor Analog, Reduces Visceral Fat in HIV-Associated Lipodystrophy. New England Journal of Medicine.
    https://www.nejm.org/doi/full/10.1056/NEJMoa0905958

  3. Raun K, et al. (1998). Ipamorelin, the first selective growth hormone secretagogue. European Journal of Endocrinology.
    https://eje.bioscientifica.com/view/journals/eje/139/5/569.xml

  4. Veldhuis JD, et al. (2005). Mechanisms of Growth Hormone Secretion in Health and Disease. Endocrine Reviews.
    https://academic.oup.com/edrv/article/26/6/753/2355337

  5. Frohman LA, et al. (2000). Regulation of Growth Hormone Secretion. Physiological Reviews.
    https://journals.physiology.org/doi/full/10.1152/physrev.2000.80.2.681

Mechanism of Action
  • GHRH Receptor Activation (Tesamorelin): Stimulates pituitary somatotrophs via cAMP/PKA pathways to release GH [Falutz 2010].

  • Ghrelin Receptor (GHSR-1a) Activation (Ipamorelin): Binds to ghrelin receptors, enhancing GH pulsatility through calcium-dependent pathways [Raun 1998].

  • Synergistic GH Release: Dual stimulation increases both amplitude and frequency of GH pulses [Bowers 2001].

  • IGF-1 Upregulation: Elevated GH leads to hepatic IGF-1 production, driving anabolic and metabolic effects [Veldhuis 2005].

  • Lipid & Glucose Regulation: Modulates adipocyte metabolism and improves insulin sensitivity [Falutz 2010].


References

  1. Bowers CY. (2001). Growth Hormone Secretagogues: Basic Principles and Clinical Implications. Endocrine Reviews.
    https://academic.oup.com/edrv/article/22/6/723/2425349

  2. Falutz J, et al. (2010). Tesamorelin, a Growth Hormone–Releasing Factor Analog, Reduces Visceral Fat in HIV-Associated Lipodystrophy. New England Journal of Medicine.
    https://www.nejm.org/doi/full/10.1056/NEJMoa0905958

  3. Raun K, et al. (1998). Ipamorelin, the first selective growth hormone secretagogue. European Journal of Endocrinology.
    https://eje.bioscientifica.com/view/journals/eje/139/5/569.xml

  4. Veldhuis JD, et al. (2005). Mechanisms of Growth Hormone Secretion in Health and Disease. Endocrine Reviews.
    https://academic.oup.com/edrv/article/26/6/753/2355337

  5. Frohman LA, et al. (2000). Regulation of Growth Hormone Secretion. Physiological Reviews.
    https://journals.physiology.org/doi/full/10.1152/physrev.2000.80.2.681

tesamorelin/ipamorelin – 10mg
woocommerce placeholder
Shopping Cart
6 10

Welcome to Novara Peptides

By entering this website, you confirm that you are at least 21 years of age and understand: that all products are sold strictly for research use only, for in vitro laboratory use. These products are not approved by the FDA for human or animal consumption, administration, or any form of bodily introduction, as prohibited by law.

DISCLAIMER: All products sold by Novara Peptides are strictly intended for laboratory research use only. They are not approved for human or animal consumption, or for any form of therapeutic or diagnostic use. We do not provide usage instructions, dosing guidelines, or any advice regarding the application of our products. ionpeptide.com is a research supply company only.